Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study
<i>Background and Objective:</i> Although Down syndrome is the most frequent aneuploidy, its pathogenic molecular mechanisms are not yet fully understood. The aim of our study is to quantify—by qRT-PCR—the expression levels of both the mature forms and the pri-miRNAs...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/11/728 |
id |
doaj-62f6be1c54764e3c9a48936368d17e8c |
---|---|
record_format |
Article |
spelling |
doaj-62f6be1c54764e3c9a48936368d17e8c2020-11-25T00:04:24ZengMDPI AGMedicina1010-660X2019-11-01551172810.3390/medicina55110728medicina55110728Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot StudyAnda-Cornelia Vizitiu0Danae Stambouli1Anca-Gabriela Pavel2Maria-Cezara Muresan3Diana Maria Anastasiu4Cristina Bejinar5Anda Alexa6Catalin Marian7Ioan Ovidiu Sirbu8Laurentiu Sima9Doctoral School, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaCytoGenomic Medical Laboratory, Calea Floreasca Nr. 35, Sector 1, Bucharest 014451, RomaniaCytoGenomic Medical Laboratory, Calea Floreasca Nr. 35, Sector 1, Bucharest 014451, RomaniaObstetrics and Gynecology Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaObstetrics and Gynecology Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaBiochemistry Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaBiochemistry Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaBiochemistry Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaBiochemistry Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, RomaniaSurgical Semiology Department, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Nr. 2, Timisoara 300041, Romania<i>Background and Objective:</i> Although Down syndrome is the most frequent aneuploidy, its pathogenic molecular mechanisms are not yet fully understood. The aim of our study is to quantify—by qRT-PCR—the expression levels of both the mature forms and the pri-miRNAs of the microRNAs resident on chromosome 21 (miR(21)) in the amniotic fluid samples from Down syndrome singleton pregnancies and to estimate the impact of the differentially expressed microRNAs on Down syndrome fetal heart and amniocytes transcriptomes. <i>Materials and methods:</i> We collected amniotic fluid samples harvested by trained obstetricians as part of the second trimester screening/diagnostic procedure for aneuploidies to assess the trisomy 21 status by QF-PCR and karyotyping. Next, we evaluated—by Taqman qRT-PCR—the expression levels of both the mature forms and the pri-miRNA precursors of the microRNAs resident on chromosome 21 in amniotic fluid samples from singleton Down syndrome and euploid pregnancies. Further, we combined miRWalk 3.0 microRNA target prediction with GEO DataSets analysis to estimate the impact of hsa-miR-99a abnormal expression on Down syndrome heart and amniocytes transcriptome. <i>Results:</i> We found a statistically significant up-regulation of the mature form of miR-99a, but not pri-miR-99a, in the amniotic fluid samples from Down syndrome pregnancies with female fetuses. GATHER functional enrichment analysis of miRWalk3.0-predicted targets from Down syndrome amniocytes and fetal hearts transcriptome GEODataSets outlined both focal adhesion and cytokine−cytokine receptor interaction signaling as novel signaling pathways impacted by miR-99a and associated with cardiac defects in female Down syndrome patients. <i>Conclusions:</i> The significant overexpression of miR-99a, but not pri-miR-99a, points towards an alteration of the post-transcriptional mechanisms of hsa-miR-99a maturation and/or stability in the female trisomic milieu, with a potential impact on signaling pathways important for proper development of the heart.https://www.mdpi.com/1010-660X/55/11/728down syndromeamniotic fluidpregnancymicrornacardiac defects |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anda-Cornelia Vizitiu Danae Stambouli Anca-Gabriela Pavel Maria-Cezara Muresan Diana Maria Anastasiu Cristina Bejinar Anda Alexa Catalin Marian Ioan Ovidiu Sirbu Laurentiu Sima |
spellingShingle |
Anda-Cornelia Vizitiu Danae Stambouli Anca-Gabriela Pavel Maria-Cezara Muresan Diana Maria Anastasiu Cristina Bejinar Anda Alexa Catalin Marian Ioan Ovidiu Sirbu Laurentiu Sima Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study Medicina down syndrome amniotic fluid pregnancy microrna cardiac defects |
author_facet |
Anda-Cornelia Vizitiu Danae Stambouli Anca-Gabriela Pavel Maria-Cezara Muresan Diana Maria Anastasiu Cristina Bejinar Anda Alexa Catalin Marian Ioan Ovidiu Sirbu Laurentiu Sima |
author_sort |
Anda-Cornelia Vizitiu |
title |
Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study |
title_short |
Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study |
title_full |
Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study |
title_fullStr |
Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study |
title_full_unstemmed |
Mature miR-99a Upregulation in the Amniotic Fluid Samples from Female Fetus Down Syndrome Pregnancies: A Pilot Study |
title_sort |
mature mir-99a upregulation in the amniotic fluid samples from female fetus down syndrome pregnancies: a pilot study |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X |
publishDate |
2019-11-01 |
description |
<i>Background and Objective:</i> Although Down syndrome is the most frequent aneuploidy, its pathogenic molecular mechanisms are not yet fully understood. The aim of our study is to quantify—by qRT-PCR—the expression levels of both the mature forms and the pri-miRNAs of the microRNAs resident on chromosome 21 (miR(21)) in the amniotic fluid samples from Down syndrome singleton pregnancies and to estimate the impact of the differentially expressed microRNAs on Down syndrome fetal heart and amniocytes transcriptomes. <i>Materials and methods:</i> We collected amniotic fluid samples harvested by trained obstetricians as part of the second trimester screening/diagnostic procedure for aneuploidies to assess the trisomy 21 status by QF-PCR and karyotyping. Next, we evaluated—by Taqman qRT-PCR—the expression levels of both the mature forms and the pri-miRNA precursors of the microRNAs resident on chromosome 21 in amniotic fluid samples from singleton Down syndrome and euploid pregnancies. Further, we combined miRWalk 3.0 microRNA target prediction with GEO DataSets analysis to estimate the impact of hsa-miR-99a abnormal expression on Down syndrome heart and amniocytes transcriptome. <i>Results:</i> We found a statistically significant up-regulation of the mature form of miR-99a, but not pri-miR-99a, in the amniotic fluid samples from Down syndrome pregnancies with female fetuses. GATHER functional enrichment analysis of miRWalk3.0-predicted targets from Down syndrome amniocytes and fetal hearts transcriptome GEODataSets outlined both focal adhesion and cytokine−cytokine receptor interaction signaling as novel signaling pathways impacted by miR-99a and associated with cardiac defects in female Down syndrome patients. <i>Conclusions:</i> The significant overexpression of miR-99a, but not pri-miR-99a, points towards an alteration of the post-transcriptional mechanisms of hsa-miR-99a maturation and/or stability in the female trisomic milieu, with a potential impact on signaling pathways important for proper development of the heart. |
topic |
down syndrome amniotic fluid pregnancy microrna cardiac defects |
url |
https://www.mdpi.com/1010-660X/55/11/728 |
work_keys_str_mv |
AT andacorneliavizitiu maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT danaestambouli maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT ancagabrielapavel maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT mariacezaramuresan maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT dianamariaanastasiu maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT cristinabejinar maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT andaalexa maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT catalinmarian maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT ioanovidiusirbu maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy AT laurentiusima maturemir99aupregulationintheamnioticfluidsamplesfromfemalefetusdownsyndromepregnanciesapilotstudy |
_version_ |
1725429650706923520 |